Abstract:Key PointsQuestionWhat are the prevalence rates of and odds for depression and anxiety in adults with hidradenitis suppurativa? FindingsThis systematic review and meta-analysis of 10 studies comprising 40307 participants with hidradenitis suppurativa found a prevalence of depression of 16.9% and a prevalence of anxiety of 4.9%. The odds ratio for depression among people with hidradenitis suppurativa was 1.84. MeaningDepression and anxiety are common comorbidities in people with hidradenitis suppurativa; efforts toward recognition, prevention, and management of those psychiatric comorbidities are warranted. This systematic review and meta-analysis evaluates 10 observational studies to assess the prevalence of depression and anxiety in patients with hidradenitis suppurativa and the odds of these psychiatric disorders in this population. ImportancePrevious studies suggest that depression and anxiety are common in patients with hidradenitis suppurativa (HS), more so than other dermatological conditions. Yet, to the authors' knowledge, no previous systematic review or meta-analysis has estimated the prevalence or odds ratio (OR) for those psychiatric comorbidities in this population. ObjectiveTo assess the prevalence and odds for depression and anxiety in patients with HS. Data SourcesFrom July 25 to September 30, 2018, observational studies investigating the prevalence and odds for depression and anxiety in adults with HS were systematically searched without language restriction from the inception of each database to July 25, 2018, in PubMed/MEDLINE, Embase, and PsycINFO databases. Searches used various configurations of the terms hidradenitis suppurativa; acne inversa; depressive disorder; depression; anxiety; anxiety disorders; phobia, social; suicide; and suicide, attempted. In addition, the reference lists of included references were screened manually. Study SelectionTwo investigators independently screened references that measured prevalence rates and odds for depressive and anxiety symptoms in patients with HS. Of 136 unique references, 10 ultimately met inclusion criteria. Data Extraction and SynthesisRelevant data were extracted from eligible references. Authors were contacted to provide further information when necessary. Methodological quality of included studies was assessed through a modified version of the Newcastle-Ottawa Scale. Random-effects models were used to synthesize available evidence. Main Outcomes and MeasuresPrevalence rates and ORs for depression and anxiety in adults with HS were the primary outcome measures. Heterogeneity across studies was assessed with the I-2 statistic. Sources of heterogeneity were explored through subgroup and meta-regression analyses. ResultsTen studies comprising 40307 participants with HS met inclusion criteria. The overall prevalence of depression was 16.9% (95% CI, 9.9%-27.2%). Heterogeneity was large. In the subgroup of studies that considered a clinical criteria-based diagnosis of depression, the prevalence of depression was 11.9% (95% CI, 4.9%-26.2%), compared with 26.8% (95% CI, 20.4%-34.5%) in studies that used a screening instrument. The methodological quality of included studies moderated those findings. The OR for depression in individuals with HS compared with individuals without HS was 1.84 (95% CI, 1.57-2.15). The prevalence of anxiety was 4.9% (95% CI, 1.7%-13.2%); there were insufficient data to determine an odds ratio for anxiety in persons with HS because 2 studies included a comparison group. Conclusions and RelevanceThis systematic review and meta-analysis indicates that depression and anxiety are common comorbid conditions in patients with HS. Results suggest that the development of strategies to recognize and treat those psychiatric comorbidities in patients with HS is warranted.

The Prevalence of Anxiety and Depression in Patients with or Without Hyperhidrosis (HH).

Hyperhidrosis Prevalence And Demographical Characteristics In Dermatology Outpatients In Shanghai And Vancouver

Risk Factors for Anxiety in Major Depressive Disorder Patients

Prevalence and Strong Association of High Somatic Symptom Severity with Depression and Anxiety in a Chinese Inpatient Population

Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin

Cross-sectional Investigation and Analysis of Anxiety and Depression in Preoperative Patients in the Outpatient Department of Aesthetic Plastic Surgery in a General Hospital in China.

Treatment Patterns, Depression, and Anxiety Among US Patients Diagnosed with Hyperhidrosis: A Retrospective Cohort Study

Relationship between depression scores and degree of skin perspiration: A novel cross-sectional study

Depression and Anxiety in Adults with Hidradenitis Suppurativa

The Impact of COVID-19 on Hyperhidrosis Patients in the Mental Health and Quality of Life: A Web-Based Surveillance Study

Clinico-epidemiological Profile of Primary Hyperhidrosis in Indian Patients: Single-center Experience

Depression and Anxiety in Adults With Hidradenitis Suppurativa: A Systematic Review and Meta-analysis.

Prevalence and Risk Factors of Anxiety and Depression in Patients with Postherpetic Neuralgia: A Retrospective Study

Investigation on aetiological factors in patients with hyperhidrosis

Prevalence of depression and anxiety and their predictors among patients undergoing maintenance hemodialysis in Northern China: a cross-sectional study

A Cross-sectional Survey on the Prevalence of Depressive And/or Anxiety Disorder in Coronary Heart Disease Cases in General Hospitals

Primary hyperhidrosis: Prevalence, severity, and impact on quality of life among Jordanian patients

Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects

Incidence of anxiety disorder among adults with hidradenitis suppurativa

Health Anxiety in Medical Employees: A Multicentre Study

Anxiety and Depression in Patients With Physical Diseases and Associated Factors: A Large-Scale Field Survey in General Hospitals in China